Pharma Stocks Rated in Buy
Explore our handpicked list of Pharma Stocks with a 'Buy' rating from external analysts. These pharmaceutical and healthcare companies have been identified as having strong growth prospects and solid fundamentals, offering investors the opportunity to capitalize on the potential of the pharma market. (Analyst Data curated by S&P Global)
| Name | Analyst Rating | Price | Target Price | M Cap | Alpha | 1Y Return | 3Y Return | 5Y Return | PE | Industry PE | PB | Beta | Div Yld | Net Profit Qtr | Net Profit QoQ % | Net Profit YoY % | Net Profit 3Y Change % | Rev Qtr (in Cr) | Rev QoQ (in %) | Rev 1Y change % | Rev 3Y change % | Profit Mar Qtr | Profit Mar QoQ | Profit Mar 1Y Change% | Profit Mar 3Y Change% | Sector | M Cap | ROE | ROCE | EPS | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BUY | ₹1,905.80 | 1990 | Large Cap | 13.6% | 8.55% | 102.03% | 171.89% | 41.28 | 45.6 | 17.11 | 0.55 | 0.92% | 3401.09 Cr | 8.42% | 13.8% | 222.39% | 15469.07 | 7.39% | 8.42% | 36.02% | 20.88% | 0.96% | 4.97% | 137.02% | Basic Materials | 450643.09 | 17.83% | 16.29% | 45.76 | 3456331 | |
| BUY | ₹6,835.00 | 6822.5 | Large Cap | 14.45% | 2.74% | 114.38% | 68.01% | 72.41 | 45.6 | 10.27 | 0.6 | 0.52% | 583 Cr | 36.94% | 2604 | 19.31% | 4.47% | 23.41% | 14.77% | Basic Materials | 179470.03 | 15.57% | 20.63% | 82.68 | 340352 | ||||||
| BUY | ₹4,393.70 | 4544 | Large Cap | 40.6% | 33.39% | 167% | 223.51% | 65.55 | 45.6 | 14.42 | 0.33 | 0.19% | 635 Cr | 7.45% | 15.39% | 145.92% | 3251 | 0.15% | 7.35% | 35.36% | 16.6% | 7.28% | 7.49% | 81.69% | Basic Materials | 149108.91 | 26.18% | 26.84% | 56.47 | 329331 | |
| BUY | ₹1,426.20 | 1472.5 | Large Cap | 0.99% | 56.6% | 61.93% | 29.81 | 45.6 | 3.63 | 0.65 | 1.11% | 550.11 Cr | 27.33% | 106.72% | 6464.26 | 6.88% | 26.58% | 19.21% | 19.13% | 63.32% | Basic Materials | 115685.12 | 17.17% | 21.4% | 65.52 | 2013605 | |||||
| BUY | ₹2,495.70 | 2500 | Mid Cap | 3.44% | 84.61% | 75.98% | 58.07 | 45.6 | 6.83 | 0.73 | NA | 413.88 Cr | 3.57% | 38.42% | 3567.2 | 18.98% | 56.88% | 16.47% | Pharmaceuticals | 103330.93 | 13.89% | 14.88% | 48.74 | 314252 | |||||||
| BUY | ₹1,500.50 | 1425 | Mid Cap | 29.89% | 25.37% | 152.05% | 50.56% | 25.18 | 45.6 | 3.28 | 0.6 | NA | 909.8 Cr | 7.27% | 9.93% | 31.6% | 8604.51 | 4.46% | 9.39% | 35.25% | 10.98% | 2.69% | 0.5% | Basic Materials | 87805.59 | 8.68% | 10.82% | 59.98 | 939496 | ||
| BUY | ₹426.25 | 417.5 | Mid Cap | 32.68% | 25.91% | 75.52% | 11.71% | 154.16 | 45.6 | 3.55 | 0.77 | 0.15% | 198.6 Cr | 10.14% | 85.25% | 4484.3 | 8.76% | 3.43% | 86.48% | 9.37% | 6.49% | Basic Materials | 69715.24 | 0.4% | 2.07% | 11.91 | 3394086 | ||||
| BUY | ₹2,339.90 | 2350 | Mid Cap | 66.4% | 61.69% | 285.02% | 282.2% | 61.63 | 45.6 | 1.77 | 0.68 | 0.16% | 403.23 Cr | 5.38% | 3888 | 12.77% | 8.26% | 7.86% | 2% | Basic Materials | 65637.09 | 6.78% | 8.94% | 37.11 | 429194 | ||||||
| BUY | ₹27,925.00 | 33950 | Mid Cap | 33.23% | 74.04% | 0 | 45.6 | 15.43 | 0.33 | NA | 394.93 Cr | 5.05% | 17.75% | 77.09% | 1709.51 | 9.71% | 31.03% | 21.94% | 5.94% | 7.33% | 35.15% | Basic Materials | 59372.5 | 35.66% | 44.95% | 0 | 12613 | ||||
| BUY | ₹788.85 | 772.5 | Mid Cap | 12.91% | 7.25% | 7.25% | 7.25% | 90.55 | 45.6 | 0 | 0.8 | NA | 92.82 Cr | 22.86% | 11.27% | 423.15 | 29.96% | 49.81% | 24.46% | Pharmaceuticals | 43999.05 | 22.98% | 30.46% | 0 | 210253 | ||||||
| BUY | ₹2,389.80 | 2725 | Mid Cap | 90.31% | 60.82% | 40.57 | 45.6 | 25.01 | 0.66 | 1.88% | 277.86 Cr | 57.23% | 995.3 | 8.56% | 14.37% | 24.74% | 44.84% | Basic Materials | 41314.74 | 49.23% | 58.72% | 54.76 | 70066 | ||||||||
| BUY | ₹1,646.30 | 1712.5 | Mid Cap | 19.8% | 11.71% | 137.72% | 48.38% | 44.76 | 45.6 | 5.53 | 0.03 | 0.27% | 364.05 Cr | 28.41% | 48.81% | 2392.5 | 16.02% | 53.34% | 8.81% | 37.22% | 28.26% | Basic Materials | 40719.53 | 12.39% | 17.21% | 31.04 | 634585 |
